United States: Addressing Breach Of Method-Of-Use Patents By Generics – Mondaq
Sandoz Inc., Nos. 2011-1143, -1228 (Yasmin), affirmed a district court's holding that as a matter of law, generic drug makers could not infringe patent claims reciting a method of use of a U.S. Food and Drug Administration (FDA)-approved drug where the FDA ...
Subscribe to LegalLaw247.Com Newsletter